CN1C(=O)[C@H]2c3c([nH]c4ccccc34)[C@@H]3[C@@H](c4ccccc4N3S(=O)(=O)C(F)(F)F)[C@H]2C1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?